Search Results - "IRVINE, G. Brent"

Refine Results
  1. 1

    Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases by Irvine, G Brent, El-Agnaf, Omar M, Shankar, Ganesh M, Walsh, Dominic M

    Published in Molecular medicine (Cambridge, Mass.) (01-07-2008)
    “…Developing effective treatments for neurodegenerative diseases is one of the greatest medical challenges of the 21st century. Although many of these clinical…”
    Get full text
    Journal Article
  2. 2

    novel reciprocal and biphasic relationship between membrane cholesterol and β-secretase activity in SH-SY5Y cells and in human platelets by Liu, Wei Wei, Todd, Stephen, Coulson, David T.R, Brent Irvine, G, Peter Passmore, A, McGuinness, Bernadette, McConville, Maeve, Craig, David, Johnston, Janet A

    Published in Journal of neurochemistry (2009)
    “…Research into the cause of Alzheimer's disease (AD) has identified strong connections to cholesterol. Cholesterol and cholesterol esters can modulate amyloid…”
    Get full text
    Journal Article
  3. 3

    ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain by Beyer, Nancy, Coulson, David Tr, Heggarty, Shirley, Ravid, Rivka, Irvine, G Brent, Hellemans, Jan, Johnston, Janet A

    Published in Molecular neurodegeneration (23-12-2009)
    “…ZnT3 is a membrane Zn(2+ )transporter that is responsible for concentrating Zn(2+ )into neuronal presynaptic vesicles. Zn(2+ )homeostasis in the brain is…”
    Get full text
    Journal Article
  4. 4

    Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue by Coulson, David T R, Brockbank, Simon, Quinn, Joseph G, Murphy, Suzanne, Ravid, Rivka, Irvine, G Brent, Johnston, Janet A

    Published in BMC molecular biology (06-05-2008)
    “…Studies of gene expression in post mortem human brain can contribute to understanding of the pathophysiology of neurodegenerative diseases, including…”
    Get full text
    Journal Article
  5. 5

    Familial genes in sporadic disease: Common variants of α- synuclein gene associate with Parkinson's disease by Ross, Owen A., Gosal, David, Stone, Jeremy T., Lincoln, Sarah J., Heckman, Michael G., Irvine, G. Brent, Johnston, Janet A., Gibson, J. Mark, Farrer, Matthew J., Lynch, Timothy

    Published in Mechanisms of ageing and development (01-05-2007)
    “…Genetic variation of the α- synuclein gene ( SNCA) is known to cause familial parkinsonism, however the role of SNCA variants in sporadic Parkinson's disease…”
    Get full text
    Journal Article
  6. 6

    Zinc transporter mRNA levels in Alzheimer's disease postmortem brain by Beyer, Nancy, Coulson, David T R, Heggarty, Shirley, Ravid, Rivka, Hellemans, Jan, Irvine, G Brent, Johnston, Janet A

    Published in Journal of Alzheimer's disease (01-01-2012)
    “…Zinc (Zn2+) is concentrated into pre-synaptic vesicles and co-released with neurotransmitter at some synapses. Zn2+ can accelerate assembly of the amyloid-β…”
    Get more information
    Journal Article
  7. 7

    α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease by Quinn, Joseph G, Coulson, David T.R, Brockbank, Simon, Beyer, Nancy, Ravid, Rivka, Hellemans, Jan, Irvine, G. Brent, Johnston, Janet A

    Published in Brain research (12-06-2012)
    “…Abstract α-Synuclein is a neuronal protein implicated in the etiology of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Whilst increased…”
    Get full text
    Journal Article
  8. 8

    BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue by Coulson, David T R, Beyer, Nancy, Quinn, Joe G, Brockbank, Simon, Hellemans, Jan, Irvine, G Brent, Ravid, Rivka, Johnston, Janet A

    Published in Journal of Alzheimer's disease (01-01-2010)
    “…β-site AβPP cleaving enzyme 1 (BACE1) catalyses the rate-limiting step for production of amyloid-β (Aβ) peptides, involved in the pathological cascade…”
    Get more information
    Journal Article
  9. 9

    Inhibitors of α-synuclein oligomerization and toxicity : a future therapeutic strategy for Parkinson's disease and related disorders by AMER, Dena A. M, IRVINE, G. Brent, EL-AGNAF, Omar M. A

    Published in Experimental brain research (01-08-2006)
    “…An abundance of genetic, histopathological, and biochemical evidence has implicated the neuronal protein, alpha-synuclein (alpha-syn) as a key player in the…”
    Get full text
    Conference Proceeding Journal Article
  10. 10

    Identification of the region of non‐Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity by Bodles, Angela M., Guthrie, David J. S., Greer, Brett, Irvine, G. Brent

    Published in Journal of neurochemistry (01-07-2001)
    “…The non‐beta‐amyloid (Aβ) component of Alzheimer's disease amyloid (NAC) and its precursor α‐synuclein have been linked to amyloidogenesis in several…”
    Get full text
    Journal Article
  11. 11

    IQ motif selectivity in human IQGAP1: binding of myosin essential light chain and S100B by Pathmanathan, Sevvel, Elliott, Sarah F, McSwiggen, Sara, Greer, Brett, Harriott, Pat, Irvine, G. Brent, Timson, David J

    Published in Molecular and cellular biochemistry (01-11-2008)
    “…IQGAPs are cytoskeletal scaffolding proteins which link signalling pathways to the reorganisation of actin and microtubules. Human IQGAP1 has four IQ motifs…”
    Get full text
    Journal Article
  12. 12

    Inhibition of fibril formation and toxicity of a fragment of α-synuclein by an N-methylated peptide analogue by Bodles, Angela M., El-Agnaf, Omar M.A., Greer, Brett, Guthrie, David J.S., Irvine, G.Brent

    Published in Neuroscience letters (08-04-2004)
    “…α-Synuclein has been linked to amyloidogenesis in Parkinson's disease and other neurodegenerative disorders. We have previously shown that a peptide comprising…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Alpha-synuclein aggregation by Bodles, Angela M, Irvine, G Brent

    Published in Protein and peptide letters (01-06-2004)
    “…Alpha-synuclein is a major component of Lewy bodies in Parkinson's disease and is found associated with several other forms of dementia. As with other…”
    Get more information
    Journal Article
  17. 17

    Determination of molecular size by size-exclusion chromatography (gel filtration) by Irvine, G B

    Published in Current protocols in cell biology (01-04-2000)
    “…Size-exclusion or gel filtration chromatography is one of the most popular methods for determining the sizes of proteins. Proteins in solution, or other…”
    Get more information
    Journal Article
  18. 18

    High-performance size-exclusion chromatography of peptides by Irvine, G.Brent

    “…Gel filtration on soft gels has been employed for over 40 years for the separation, desalting and molecular weight estimation of peptides and proteins…”
    Get full text
    Book Review Journal Article
  19. 19

    Serum neurone-specific enolase levels in patients with neuroendocrine and carcinoid tumours by Cunningham, R T, Johnston, C F, Irvine, G B, Buchanan, K D

    Published in Clinica chimica acta (30-11-1992)
    “…We have examined concentrations of neurone-specific enolase (NSE) in sera from 18 patients with various neuroendocrine tumours, 26 patients with carcinoid…”
    Get more information
    Journal Article
  20. 20

    Visual detection of peptidase activity using fluorogenic substrates in a microtiter plate assay by Irvine, G B, Ennis, M, Williams, C H

    Published in Analytical biochemistry (01-03-1990)
    “…A simple, inexpensive, and sensitive assay for peptidase activity has been devised. The assay was performed in a microtiter plate and was based on fluorogenic…”
    Get more information
    Journal Article